AstraZeneca and Daiichi Sankyo win U.S. approval for breast cancer drug ...Middle East

japan times - News
 AstraZeneca and Daiichi Sankyo win U.S. approval for breast cancer drug
The Food and Drug Administration approved the drug for patients with advanced breast tumors whose cells bear a certain genetic signature.

Read More Details
Finally We wish PressBee provided you with enough information of ( AstraZeneca and Daiichi Sankyo win U.S. approval for breast cancer drug )

Apple Storegoogle play

Also on site :